Heart Test Laboratories Net Income
| HSCSW Stock | USD 0.08 0.04 34.08% |
As of the 25th of February, Heart Test retains the risk adjusted performance of 0.101, and Market Risk Adjusted Performance of (0.37). Heart Test technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Heart Test Laboratories standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Heart Test is priced fairly, providing market reflects its last-minute price of 0.0791 per share. As Heart Test Laboratories appears to be a penny stock we also urge to confirm its total risk alpha numbers.
Heart Test Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -7.9 M | -8.3 M | |
| Net Loss | -7.9 M | -8.3 M | |
| Net Loss | (8.41) | (8.83) |
Heart | Net Income | Build AI portfolio with Heart Stock |
The evolution of Net Income for Heart Test Laboratories provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Heart Test compares to historical norms and industry peers.
Latest Heart Test's Net Income Growth Pattern
Below is the plot of the Net Income of Heart Test Laboratories over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Heart Test Laboratories financial statement analysis. It represents the amount of money remaining after all of Heart Test Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Heart Test's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (8.77 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Heart Net Income Regression Statistics
| Arithmetic Mean | (4,899,305) | |
| Coefficient Of Variation | (38.93) | |
| Mean Deviation | 1,576,476 | |
| Median | (3,811,118) | |
| Standard Deviation | 1,907,130 | |
| Sample Variance | 3.6T | |
| Range | 6.3M | |
| R-Value | (0.77) | |
| Mean Square Error | 1.6T | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | (290,492) | |
| Total Sum of Squares | 58.2T |
Heart Net Income History
Other Fundumenentals of Heart Test Laboratories
Heart Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Heart Test is extremely important. It helps to project a fair market value of Heart Stock properly, considering its historical fundamentals such as Net Income. Since Heart Test's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heart Test's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heart Test's interrelated accounts and indicators.
Click cells to compare fundamentals
Search Suggestions
| HSC | HSC | Cryptocurrency |
| HSCC | Homeland Security Cp | Company |
| HSCSX | Small Company Stock Fund | Mutual Fund |
| HSCZ | iShares Currency Hedged | ETF |
| HSC | Enviri | CompanyDelisted |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionHeart Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Heart Test Laboratories reported net income of (8.77 Million). This is 102.57% lower than that of the Health Care Equipment & Supplies sector and 103.68% lower than that of the Health Care industry. The net income for all United States stocks is 101.54% higher than that of the company.
Heart Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heart Test's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics of similar companies.Heart Test is currently under evaluation in net income category among its peers.
Heart Fundamentals
| Return On Equity | -2.2 | ||||
| Return On Asset | -0.75 | ||||
| Operating Margin | (857.13) % | ||||
| Revenue | 4.35 K | ||||
| Gross Profit | 5.02 K | ||||
| EBITDA | (8.14 M) | ||||
| Net Income | (8.77 M) | ||||
| Cash And Equivalents | 723.48 K | ||||
| Cash Per Share | 0.22 X | ||||
| Total Debt | 2.99 M | ||||
| Current Ratio | 0.59 X | ||||
| Book Value Per Share | 1.36 X | ||||
| Cash Flow From Operations | (7.41 M) | ||||
| Earnings Per Share | (1.09) X | ||||
| Number Of Employees | 15 | ||||
| Beta | 2.54 | ||||
| Total Asset | 4.22 M | ||||
| Retained Earnings | (76.13 M) | ||||
| Working Capital | (1.53 M) | ||||
| Net Asset | 4.22 M |
About Heart Test Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heart Test Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heart Test using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heart Test Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.